DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
RNA polymerase	R-HSA-73864	map03020	dorzolamide	5284549	drug-path
Pathways in cancer	R-HSA-9824443	map05200	meropenem	5481173	drug-path
Olfactory transduction	R-HSA-9751605	map04740	meropenem	5481173	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	meropenem	5481173	drug-path
Adipocytokine signaling pathway	R-HSA-168638	map04920	meropenem	5481173	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	meropenem	5481173	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	glafenine	4641	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	glafenine	4641	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	glafenine	4641	drug-path
Amyotrophic lateral sclerosis (ALS)	Q8NDH6-2	0	glafenine	4641	drug-path
Apoptosis	R-HSA-109581	map04210	glafenine	4641	drug-path
Long-term potentiation	R-HSA-9620244	map04720	glafenine	4641	drug-path
Asthma	R-HSA-444620	map05310	glafenine	4641	drug-path
TGF-beta signaling pathway	R-HSA-168638	map04350	glafenine	4641	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	glafenine	4641	drug-path
Allograft rejection	R-HSA-9679028	map05330	glafenine	4641	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	glafenine	4641	drug-path
Adherens junction	R-HSA-451386	map04520	dyclonine	68783	drug-path
Melanogenesis	R-HSA-5662702	map04916	dyclonine	68783	drug-path
Glioma	Q9NZM4	map05214	dyclonine	68783	drug-path